|
|
Immune stimulation during chemotherapy increases incidence of acute graft versus host disease in acute myeloid leukemia: A study on behalf of SFGM-TC and ALFA
Lining Wang
,
Emmanuel Raffoux
,
Xavier Thomas
,
Ibrahim Yakoub-Agha
,
Jean-Henri Bouhris
et al.
Article dans une revue
hal-01557470v1
|
Partager
Gmail
Facebook
Twitter
LinkedIn
More
|
|
|
Deep-Learning Assessed Muscular Hypodensity Independently Predicts Mortality in DLBCL Patients Younger Than 60 Years
Maxime Jullien
,
Benoit Tessoulin
,
Hervé Ghesquières
,
Lucie Oberic
,
Franck Morschhauser
et al.
Article dans une revue
inserm-03540506v1
|
Partager
Gmail
Facebook
Twitter
LinkedIn
More
|
|
|
PET-adapted treatment for newly diagnosed advanced Hodgkin lymphoma (AHL2011): a randomised, multicentre, non-inferiority, phase 3 study
Rene-Olivier Casasnovas
,
Reda Bouabdallah
,
Pauline Brice
,
Julien Lazarovici
,
Hervé Ghesquieres
et al.
Lancet Oncology, 2019
Article dans une revue
hal-01996114v1
|
Partager
Gmail
Facebook
Twitter
LinkedIn
More
|
|
|
Splenectomy for primary immune thrombocytopenia revisited in the era of thrombopoietin receptor agonists: New insights for an old treatment
Arthur Mageau
,
Louis Terriou
,
Mikael Ebbo
,
Odile Souchaud‐debouverie
,
Corentin Orvain
et al.
Article dans une revue
inserm-03547101v1
|
Partager
Gmail
Facebook
Twitter
LinkedIn
More
|
|
|
Lenalidomide Maintenance Compared With Placebo in Responding Elderly Patients With Diffuse Large B-Cell Lymphoma Treated With First-Line Rituximab Plus Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone
Catherine Thieblemont
,
Hervé Tilly
,
Maria Gomes Da Silva
,
Rene-Olivier Casasnovas
,
Christophe Fruchart
et al.
Article dans une revue
hal-01609346v1
|
Partager
Gmail
Facebook
Twitter
LinkedIn
More
|
|
|
Lenalidomide, Bortezomib, and Dexamethasone with Transplantation for Myeloma
Michel Attal
,
Valerie Lauwers-Cances
,
Cyrille Hulin
,
Xavier Leleu
,
Denis Caillot
et al.
Article dans une revue
hal-01557406v1
|
Partager
Gmail
Facebook
Twitter
LinkedIn
More
|
|
|
Acalabrutinib in relapsed or refractory mantle cell lymphoma (ACE-LY-004): a single-arm, multicentre, phase 2 trial
Michael Wang
,
Simon Rule
,
Pier Luigi Zinzani
,
Andre Goy
,
Olivier Casasnovas
et al.
Article dans une revue
inserm-01980627v1
|
Partager
Gmail
Facebook
Twitter
LinkedIn
More
|